Loading company…
Replicate Bioscience develops self-replicating RNA immunotherapies for cancer.
Founded in 2020 and based in California, Replicate Bioscience develops self-replicating RNA immunotherapies for treating cancer.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in